Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
1.
Indian J Med Sci ; 2010 Mar; 64(3) 99-103
Artigo em Inglês | IMSEAR | ID: sea-145493

RESUMO

Background and Objectives: Tuberculosis (TB) remains one of the major causes of death from a single infectious agent worldwide. Its resurgence in 1990s is primarily due to co-infection with HIV and the emergence of multi-drug-resistant (MDR) strains. Our objectives in this study were demonstration and grading of acid-fast bacilli in smears from sputum specimens of clinically newly diagnosed pulmonary TB patients, isolation of the organism, speciation and drug susceptibility testing of Mycobacterium tuberculosis isolates to isoniazid (H), rifampicin (R), streptomycin (S), and ethambutol (E). Materials and Methods: Sputum specimens were collected from 150 patients. Smear examination was done after Ziehl-Neelsen staining. The specimens were cultured onto Lowenstein Jensen media after Petroff's method of concentration. The growth was identified as M. tuberculosis with standard tests. Sensitivity of 50 isolates of tubercle bacilli to anti-TB drugs H, R, S, E were determined by Resistance-Ratio method. Results: Out of 150 sputum specimens examined, 62(41.3%) were smear positive. Out of these 62,56 grew on culture. 50 isolates of M. tuberculosis were picked up for drug susceptibility testing. Total of 31 (62%) were resistant to S, 14(28%) to H, 9(18%) to R, 6(12%) were resistant to E and 2 strains (4%) were resistant to H and R. Conclusion: From the small cohort, incidence of primary MDR-TB was found to be 4% in this region, which is within the expected range.


Assuntos
Estudos de Coortes , Farmacorresistência Bacteriana Múltipla , Humanos , Índia/epidemiologia , Isoniazida/uso terapêutico , Testes de Sensibilidade Microbiana/métodos , Mycobacterium tuberculosis/efeitos dos fármacos , Mycobacterium tuberculosis/isolamento & purificação , Rifampina/uso terapêutico , Tuberculose Resistente a Múltiplos Medicamentos/tratamento farmacológico , Tuberculose Resistente a Múltiplos Medicamentos/epidemiologia
2.
Artigo em Inglês | IMSEAR | ID: sea-113021

RESUMO

Bottled water is generally accepted as safe for consumption. However, its potability is uncertain. Ninety samples of Six national and 3 local brands marketed in Mangalore City were studied. Seven of these were ISI certified. Bacteriological analysis of these samples were carried out for viable count, presumtive coliform count by multiple tube method, confirmed Esch. coli count by Eijkman test and specific intestinal pathogens, such as Salmonella, Shigella and Vibrios. Thirty out of 90 samples though free from coliforms, had viable count much higher than specified by Bureau of Indian Standard. Three samples of one of the brands which is ISI not certified had Esch. coli with most probable number 18/100 ml and Salmonella typhimurium. It is concluded that bottled water can not be taken for granted to be safe.


Assuntos
Bactérias/isolamento & purificação , Contagem de Colônia Microbiana , Qualidade de Produtos para o Consumidor , Humanos , Índia , Água/normas , Microbiologia da Água
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA